Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease

Clinical Pharmacology and Therapeutics

Volumn 73, Issue 3, 2003, Pages 232-241

  Klinkhardt, Ute ^b   Bauersachs, Rupert ^b   Adams, Jan ^b   Graff, Jochen ^b   Lindhoff Last, Edeltraud ^b   Harder, Sebastian ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CD11B ANTIGEN; CD18 ANTIGEN; CLOPIDOGREL; FIBRINOGEN RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE AGGREGATION; MALE; MONOCYTE; MONOTHERAPY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; BLOOD PLATELETS; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FLOW CYTOMETRY; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MALE; MIDDLE AGED; P-SELECTIN; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROTEIN-TYROSINE-PHOSPHATASE; TICLOPIDINE;

EID: 0037374428     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2003.13     Document Type: Article

References (41)

1. Koksch M, Zeiger F, Wittig K, Pfeiffer D, Ruehlmann C. Haemostatic derangement in advanced peripheral occlusive arterial disease. Int Angiol 1999;18:256-62.
2. Woinke M, Zeiger F, Ruehlmann C, Pfeiffer D, Koksch M. Changes in signal transduction in the platelets of patients with peripheral occlusive arterial disease. Int Angiol 2000;19:345-50.
3. Reininger CB, Graf J, Reininger AJ, Spannagl M, Steckmeier B, Schweiberer L. Increased platelet and coagulatory activity indicate ongoing thrombogenesis in peripheral arterial disease. Thromb Res 1996;82:523-32.
4. Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990;75:550-4.
5. Graff J, Klinkhardt U, Schini-Kerth VB, Harder S, Franz N, Bassus S, et al. Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor. J Pharmacol Exp Ther 2002;300:952-7.
6. Evangelista VE, Manarini S, Rotondo S. Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the β2-integrin CD11b/CD18. Blood 1996;88:146-57.
7. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 1991;78:1760-9.
8. Brown KK, Henson PM, Maclouf J, Moyle M, Ely JA, Worthen GS. Neutrophil-platelet adhesion: relative roles of platelet P-selectin and neutrophil β2 (CD18) integrins. Am J Respir Cell Mol Biol 1998;18:100-10.
9. Sheikh S, Nash GB. Continuous activation and deactivation of integrin CD11b/CD18 during de novo expression enables rolling neutrophils to immobilize platelets. Blood 1996;87:5040-50.
10. Neumann FJ, Zohlnhofer D, Fakhoury L, Ott I, Gawaz M, Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol 1999;34:1420-6.
11. Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992;79:1201-5.
12. Zahler S. Acute cardiac inflammatory responses to post-ischemic reperfusion during cardiopulmonary bypass. Cardiovasc Res 1999;41:722-30.
13. Ott I, Neumann FJ, Gawaz M, Schmitt M, Schomig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 1996;94:1239-46.
14. Zeiger F, Stephan S, Hoheisel G, Pfeiffer D, Ruehlmann C, Koksch M. P-selectin expression, platelet aggregates, and platelet derived microparticle formation are increased in peripheral arterial disease. Blood Coagul Fibrinolysis 2000;11:723-8.
15. Egger G, Burda A, Obernosterer A, Mitterhammer H, Kager G, Jurgens G, et al. Blood polymorphonuclear leukocyte activation in atherosclerosis: effects of aspirin. Inflammation 2001;2:129-35.
16. TASC Working Group. Management of peripheral arterial disease (PAD). Transatlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-296.
17. Spengel FA. Available at http://www.uni-duesseldorf.de/AWMF/11/index.html. Accessed Dec 15, 2002.
18. Schmitz G, Rothe G, Ruf A, Barlage S, Tschope D, Clemetson KJ, et al. Consensus protocol for the flow cytometric characterization of platelet function. Thromb Haemost 1998;97:885-96.
19. Tarnok A, Mahnke A, Müller M, Zotz RJ. Rapid in vitro biocompatibility assay of endovascular stents by flow cytometry using platelet activation and platelet-leukocyte aggregation. Cytometry 1999;38:30-9.
20. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
21. Savi P, Labouret C, Delesque N, Guette F, Lupker J, Herbert JM P2Y(12), a new platelet ADP receptor, target of clopidogrel. Biochem Biophys Res Commun 2001;283:379-83.
22. Trumel C, Payrastre B, Plantavid M, Hechler B, Viala C, Presek P, et al. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1 -activating peptide through the late activation of phosphoinositide 3-kinase. Blood 1999;94:4156-65.
23. Storey RF, Sanderson HM, White AE, May JA, Cameron KE, Heptinstall S. The central role of the P2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br J Haematol 2000;110:925-34.
24. Aronow WS. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease. Drugs Aging 1999;15:91-101.
25. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996;348:1329-39.
26. Simon DI, Chen Z, Xu H, Li CQ, Dong J, McIntire LV, et al. Platelet glycoprotein Ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000;192:193-204.
27. Weber C, Belge KU, von Hundelshausen P, Draude G, Steppich B, Mack M, et al. Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol 2000;67:699-704.
28. Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998;31:352-8.
29. Ott I, Neumann FJ, Kenngott S, Gawaz M, Schomig A. Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction. Am J Cardiol 1998;82:938-42.
30. May AE, Neumann FJ, Gawaz M, Ott I, Walter H, Schomig A. Reduction of monocyte-platelet interaction and monocyte activation in patients receiving antiplatelet therapy after coronary stent implantation. Eur Heart J 1997;18:1913-20.
31. Storey RF, Judge HM, Wilcox RG, Heptinstall S. Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin. Thromb Haemost 2002;88:488-94.
32. Klinkhardt U, Graff J, Harder S. Clopidogrel, but not abciximab reduces platelet-leukocyte conjugates and P-selectin expression in a human ex vivo-in vitro model. Clin Pharmacol Ther 2002;71:176-85.
33. Altieri DC, Morrissey JH, Edgington TS. Adhesive receptor MAC-1 coordinates the activation of factor X on stimulated cells of monocyte and myeloid differentiation: an alternative initiation of the coagulation protease cascades. Proc Natl Acad Sci U S A 1988;85:7462-6.
34. Davey PC, Zuzel M, Kamiguti AS, Hunt JA, Aziz KA. Activation-dependent proteolytic degradation of polymorph nuclear CD11b. Br J Haematol 2000;111:934-42.
35. Fiotti N, Giansante C, Ponte E, Delbello C, Calabrese S, Zacchi T, et al. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis 1999;145:51-60.
36. Ohno N, Ichikawa H, Coe L, Kvietys PR, Granger DN, Alexander JS. Soluble selectins and ICAM-1 modulate neutrophil-endothelial adhesion and diapedesis in vitro. Inflammation 1997;21:313-34.
37. O'Brien KD, McDonald TO, Chait A. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996;93:672-82.
38. Gawaz M, Brand K, Dickfeld T, Pogatsa-Murray G, Page S, Bogner C, et al. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis 2000;148:75-85.
39. Mueck AO, Seeger H, Wallwiener D. Further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules. Exp Clin Endocrinol Diabetes 2001;109:181-3.
40. Murphy RT, Foley JB, Mulvihill N, Crean P, Walsh MJ. Impact of preexisting statin use on adhesion molecule expression in patients presenting with acute coronary syndromes. Am J Cardiol 2001;87:446-8.
41. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.